左心室壁の加厚メカニズムの多様性
Allen Cheng1, Tom C Nguyen, Marcin Malinowski
1Department of Cardiovascular and Thoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Circulation
|July 30, 2008
まとめ
静脈繊維の縮小は左心室 (LV) の全域で均一であるが,心筋シートの動態における地域的な差異は,LV壁の厚さに大きな影響を与える. これらのメカニズムを理解することは,心臓療法にとって極めて重要です.
科学分野:
- 心血管生理学 心血管の生理学
- 心臓のメカニズム 心臓のメカニズム
- バイオメディカルエンジニアリング
背景:
- 心筋繊維は,左心室 (LV) 機能に不可欠なラミネ (シート) を形成します.
- 収縮性壁の加厚は,繊維の縮小,ラミナルの拡張,加厚,切断によって引き起こされます.
- これらのメカニズムにおける地域的な変動は,依然として十分に理解されていない.
研究 の 目的:
- 縮性LV壁の加厚に寄与するメカニズムの地域的な変動性とトランスムラル分布を調査する.
- 各 LV 地域におけるシート延長,加厚,切断の役割を区分する.
主な方法:
- 羊の放射線不透明マーカーを使用して,心筋組織の4Dダイナミクスを追跡しました.
- エピカルディア,ミッドウォール,心内膜のレベルでのシストリックストレイン (周回,縦,放射) の測定.
- 定量ヒストロジーを用いて,シートダイナミクスのトランムラル貢献を決定するために,変形した菌株データ.
主要な成果:
- シストリック壁の加厚は,横の赤道領域 (1.6-1.9倍) と比較して,前面の基礎領域で有意に大きかった.
- シストリックファイバーの縮小は,すべてのトランスムラ深度および地域において一貫していました.
- 壁の厚さに対する板の厚み,延伸,切断の貢献は,地域や深さによって大きく異なっていた.
結論:
- 繊維の短縮ではなく,シートダイナミクスの地域差異が,静脈動脈の壁の厚さの変動を説明します.
- 心筋膜の構造は,線維の短縮を増幅して,地域の壁の厚さを生み出す上で重要な役割を果たします.
- 将来の心臓の介入は,効果的な治療のために,トランムラアーキテクチャと並行して,心筋細胞収縮を考慮する必要があります.
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...


